Apnimed to Present at the Oppenheimer 31st Annual Healthcare Conference

CAMBRIDGE, Mass. March 10, 2021 – Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for obstructive sleep apnea and related disorders, today announced that the Company’s management team will participate in the Oppenheimer 31st Annual...